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The epidemiology of smear positive pulmonary tuberculosis 
at Felege Hiwot Referral Hospital, Northwest Ethiopia: A 
five year retrospective study 
 




Background: Globally, tuberculosis (TB) continues to cause considerable morbidity and mortality. Ethiopia is 
among the 22 high TB burden countries reported. Currently, data regarding the magnitude of TB and associated 
factors have been released at different health facilities as part of service auditing. However, such data are not 
universally available that this study was carried out to determine the prevalence of smear positive tuberculosis and 
its associated risk factors at FelegeHiwot Referral Hospital (FHRH) over a period of five years. 
Methods: We analyzed all the records of 12,442 presumptive TB patients registered at FHRH from 2011 to 2015. 
Data on patient’s sex, age, residential address and sputum smear microscopy results were extracted from 
laboratory registration logbook. All data were entered, cleaned and analyzed using SPSS version 22 for windows. 
The proportion and trend of smear positive TB over the five years period was calculated and the overall prevalence 
of TB in these years was determined. Logistic regression model was used to analyze the association between TB 
positivity and potential associated variables; p < 0.05 was considered to be significant. 
Results: TB suspected patients were found to be characterized as male 7052 (56.7%), within the age group of 15-
29 years of age 4105 (33.0%) and were  from rural settings7841 (63.0). The number of presumptive TB patients 
visiting FHRH over the five years period was quite variable.  However, the prevalence of smear positive TB in 
each year was almost consistent, ranging from 4.2% to 6.5%. The prevalence of smear positive TB among new 
and follow up patients was at 5.2% and 4.5%, respectively. The proportion of overall burden of smear positive 
pulmonary TB was estimated at 5.2% and was found significantly associated with age group between 15-29 
(AOR: 0.45, 95% CI, 0.23-0.77), 30-44 (AOR:0.22, 95% CI, 0.15-0.32) and 45-59 (AOR:0.38, 95% CI, 0.26-
0.56).  
Conclusions: In the studied area high prevalence of smear positive TB was documented over the five years period; 
which implies inconsistent measures being taken to reduce the burden of the disease. Hence, interventions to 
decrease prevalence of TB and thereby its impacts need to be evaluated and strengthened. [Ethiop. J. Health Dev.  
2017;31(3):155-160] 
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Introduction  
Tuberculosis (TB) as a leading cause of death in the 
world continues to cause considerable morbidity and 
mortality across the world and remains one of the 
world’s biggest public health threats [1-3]. Globally 
around 9.6 million people develop TB and 1.5 million 
people die every year due to TB, of which 0.35 million 
deaths are associated with HIV-TB co-infection [1]. 
 
The burden of mortality and morbidity caused by TB is 
highly concentrated particularly in low-income 
countries. Sub-Saharan Africa, including Ethiopia, is 
the area of highest prevalence of TB and in 2015; a 
WHO report showed that Ethiopia ranks seventh 
among the world's 22 high TB load countries [1].TB 
has been recognized as a major public health problem 
in Ethiopia for more than half a century now [2]. 
 
The estimated epidemiological profile of TB in the 
country in 2014 shows that incidence, prevalence and 
mortality are estimated at 200, 190 and 32 per 100,000 
population [1]. According to a report from the 
Ethiopian Federal Ministry of Health, TB remains the 
leading cause of morbidity, the third cause of hospital 
admission (after deliveries and malaria), and the 
second cause of death (after malaria) in the country [3]. 
 
Currently, the country is enormously involved in early 
case detection, provision of enough treatment and 
prevention of transmission of TB in the community. In 
spite of such hard work, the transmission of TB and 
event of drug resistance TB strain is continuing 
challenges for TB control and prevention programs 3-
5. 
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As primarily an airborne disease [6], patients with 
sputum smear-positive spread tiny airborne droplets 
into the surrounding air during coughing, sneezing, 
speaking and laughing [7]. This is why sputum smear 
microscopy is the recommended diagnostic tool in TB 
control, whose objective is to interrupt the transmission 
of the disease. This bacteriological examination is 
remarkable by its rapidity, its specificity and its low 
cost. In a resource poor and high TB burden countries 
like Ethiopia, it is by far the most commonly 
performed test for diagnosis and follow-up of TB 
patients [8, 9]. 
 
Directly observed treatment, short-course (DOTs) 
chemotherapy is the global standard of care for treating 
TB patients [10-11]. 
 
At present, data regarding the magnitude of TB and 
associated factors have been released at different health 
facilities as part of service auditing. However, such 
data are missing from Felege Hiwot Referral Hospital 
in Bahir Dar. Moreover, there are no clear trends over 
time on the burden of smear positive TB in different 
parts of the country (expertise observation).Thus, the 
aim of this study was to determine the prevalence and 
trend of smear positive TB (morbidity) and its 
associated factors at Felege Hiwot Referral Hospital 
(FHRH) over the five years period. This study indeed 
will add knowledge on the existing literatures. 
 
Methods 
Study setting:  The study was conducted at Felege 
Hiwot Referral Hospital in Bahir Dar, which is the 
capital city of Amhara National Regional State, 565 km 
away from Addis Ababa. The hospital is a tertiary 
health care level facility serving the population of 
Bahir Dar town, the surrounding and remote areas of 
Northwest Ethiopia. The total population served by the 
hospital is about 12 million where patients come from 
different health centers or directly by themselves in 
anticipation of better services. In the hospital, DOTs 
clinic operates under the National TB and Leprosy 
Program (NTLCP) of Ethiopia, under which patients 
were diagnosed for TB, by examination of spot-
morning-spot sputum smears and now spot-spot 
strategy by Zeihel–Nieelsen staining for the presence 
of acid fast bacilli (AFB). 
 
We considered patients smear positive when any 
definite red bacilli were seen per 100 fields. When 
sputum smear is negative, doctors establish the 
diagnosis of TB primarily based on clinical grounds 
such as by using chest X-ray. 
 
Study design and data collection:  A five-year 
secondary data were collected retrospectively and 
analyzed to assess the prevalence of smear positive TB 
of 12,442 presumptive TB patients registered from 
January 2011to February 2015 at FHRH. All 
presumptive patient records were collected using data 
extraction sheet. Socio-demographic data such as 
patient's age, sex, address as well as patients sputum 
smear microscopy result were extracted from the 
laboratory registration log book. 
In accordance with the NTLCP guidelines [11] the 
following TB case classifications were applied: 
a. Smear-positive pulmonary TB (PTB+) –A 
patient with at least two initial sputum smear 
examinations positive for AFB by direct 
microscopy, or a patient with one initial smear 
examination positive for AFB by direct 
microscopy, or a patient with one initial smear 
examination positive for AFB by direct 
microscope and radiographic abnormalities 
consistent with active  PTB.18705245 
b.  Smear-negative pulmonary TB (PTB-) –A 
patient having symptoms suggestive of TB with at 
least 3 initial smear examinations that were 
negative for AFB by direct microscopy, no 
response to a course of broad spectrum antibiotics, 
followed by an additional three negative smear 
examinations by direct microscopy and 
radiological abnormalities consistent with 
pulmonary tuberculosis or a patient whose 
diagnosis is based on a culture-positive result for 
M. tuberculosis, but has three negative initial 
smear examinations by direct microscopy. 
 
Statistical analysis: All the data were entered, cleared, 
and analyzed using the SPSS statistical software 
package, Version 22.0(IBM Corp. Released 2011. IBM 
SPSS Statistics for Windows. Armonk, NY: IBM 
Corp.). 
 
Descriptive data analysis such as proportion, median 
and range were used to visualize differences within 
data. To calculate the prevalence of smear positive TB, 
the denominator we employed was the total number of 
presumptive patients (smear positive and smear 
negative once). 
 
Moreover, stepwise logistic regression model was done 
to assess factors associated with TB positivity using 
smear microscopy in terms of the odds ratio and its 
95% confidence interval (CI). Variables such as 
patients’ sex, age category, address and the year when 
they visited the hospital were included in the analysis. 
P value was set at 0.05 to indicate statistical 
significance difference. 
 
Ethical clearance: Permission was granted from 
FHRH to utilize the laboratory registered data for 
research purpose. As the date used was collected 
retrospectively from record, written informed consent 
was not required and no patient details that may link to 
the patient identity like names was used and the 
confidentially was maintained. 
 
Results  
Demographic characteristics of the study subjects:  
We have assessed AFB smear microscopy results of 
12,442 suspected and follow up patients from 
laboratory reporting logbook processed over a 5 years 
period in FHRH; a high TB and HIV setting. Of the 
total TB patients registered, 7052 (56.7%) were males 
and 5390 (43.3%) of them were females with a male to 
female ratio of 1.3. The median age of the patients was 
35 years, ranging from 1-95 years. The majority, 7841 
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(63.0%) of the subset were from urban settings.  Four 
thousand and one hundred five (33%) of the patients 
were in the age group 15-29 years (Table 1). 
 
 
Table 1: Distribution of TB suspected cases (n = 12,442) by sex, age category,  
patients residence and TB type in Felege Hiwot Referral Hospital, Bahir Dar,  

























*AFB= Acid Fast Bacilli 
 
Prevalence of smear positive pulmonary TB:  The 
prevalence of smear positive TB among newly infected 
and follow up cases was at 628 (5.2%) and 21 (4.5%), 
respectively. Overall the prevalence of smear positive 
pulmonary TB among TB suspected and follow-up 
patients was at 649/12442 (5.2%) (Table1).There was a 
significant variation (p<0.05) on the number of patients 
who came to the hospital seeking TB diagnosis and 
treatment in each year in the five years period by their 
sex, residence and age group (Table 2). 
 
 
Table 2: Distribution of suspected TB cases (n = 12,442) by year in Felege Hiwot Referral Hospital, Bahir 
Dar, North west Ethiopia, 2011-2015. 
Variable Total 
Year 
2011 2012  2013 2104 2015 P value  
Sex        
Male 7052 1297 1142 1772 868 1973  
Female  5390 1053 797 1436 679 1425 0.021 
Residence        
Urban 4601 961 729 1306 583 1022  
Rural  7811 1389 1210 1902 964 2376 0.000 
Age        
0-14 541 111 85 155 80 110  
15-29 4105 867 695 1062 493 988  
30-44 3870 748 603 988 444 1087  
45-59 2373 392 332 618 293 738  
>60 1553 232 224 385 237 475 0.000 
 
Trends of smear positive pulmonary TB over a five 
year period: It was found that the number of TB 
suspected patients visiting FHRH over the five years 
period was quite different.  We have noticed uneven 
number of TB suspected cases across the stated years.  
The highest prevalence rate at 6.6% was recorded in 
2011. However, after falling from 6.6% to 4.2%in 2012 
and 2013, it rose up to 6.1% in 2014 and falling from 
6.1% to 5.4% in 2015.The highest number of new and 
follow up smear positive pulmonary patients at 6.2% 
and 6.3%, respectively, were recorded in 2011.The 
trend over the stated periods does not show steady 
declining or increasing trend – rather erratic. However, 
the prevalence of smear positive pulmonary TB across 
the year was almost comparable. The average 
prevalence of TB among new and follow up cases in 
the five years period was 5.4% and 6.5%, respectively 
(Figure 1). 
 
Variables Frequency % 
Sex   
Male 7052  56.7 
Female 5390  43.3 
Patient residence   
Urban  4601  37.0 
Rural  7841  63.0 
Age group   
0-14 541  4.3 
15-29 4105  33.0 
30-44 3870  31.1 
45-59 2373  19.1 
   ≥60 1553  12.5 
New *AFB result   
Positive  628  5.2 
Negative  11353  94.8 
Follow up AFB  result   
Positive  21  4.5 
Negative  442  95.5 
All  AFB result   
Positive  649  5.2 
Negative  11793  94.8 
Total  12442 100 
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2011 2012 2013 2014 2015 Average 
New result 6.2 4.22 4.4 6.6 5.3 5.4
Follow up result 6.3 3.2 1.1 8.9 8.6 6.5







Trend of smear positive pulmonary TB over 5 Years period
 
 
Figure 1: *Prevalence of smear positive pulmonary TB among study participants over a five years period at 
FHRH, 2011-2015. 
*Prevalence was calculated in such a way that we used the numerator smear positive cases and the total numbers 
of presumptive patients as a denominator. 
 
Factors associated with smear positive TB:  In the 
logistic regression model, sex and patient residence 
was not found associated with smear positive TB 
positivity. Patient age group 15-29 [Adjusted OR: 0.45, 
95%CI (0.23-0.77), age group 30-44 [AOR: 0.22, 
95%CI (0.15-0.32)] and 45-59 [AOR: 0.38, 95%CI 
(0.26-0.56)] were less likely to be smear positive TB. 
In contrast, the odds of having sear positive TB was 
higher among patients diagnosed in the year 2013 and 
2014[AOR: 1.40, 95%CI; (1.07-1.83)] and [AOR: 1.34 
95%CI, (1.06-1.68)], respectively (Table 3). 
 
Table 3: Aanalysis of associated factors for sputum smear positivity among TB suspected patients in 
FHRH, 2011-2015. 




COR (95%CI) AOR (95%CI) 
Sex      
Male 7052 (56.7) 370 (5.2) 6688 (94.8) 1 1 
Female  5390 (43.3) 279 (5.2) 5111 (94..8) 0.97 (0.84-1.16) 1.13 (0.95-1.33) 
Address      
Urban 4601 (37) 245 (5.3) 4356 (94.7) 1 1 
Rural  7841 (63) 404 (5.2) 7437 (94.8) 0.97 (0.82-1.14) 0.98 (0.84-1.16) 
Age      
0-14 541 (4.3) 23 (4.3) 518 (95.7) 1 1 
15-29 4105 (33.0) 334 (8.1) 3771 (91.9) 0.46 (0.27-0.79) 0.45 (0.23-0.77)* 
30-44 3870 (31.1) 192 (5.0) 3678 (95.0) 0.23 (0.16-0.33) 0.22 (0.15-0.32)* 
45-59 2373 (19.1) 69 (2.9) 2304 (97.1) 0.39 (0.27-0.57) 0.38 (0.26-0.56)* 
≥60 1553 (12.5) 31 (2.0) 1522 (98.0) 0.68 (0.44-1.04) 0.67 (0.44-1.03) 
Year      
2011 2350 (18.9) 156 (6.6) 2194 (93.4) 1 1 
2012 1939 (15.6) 81(4.2) 1858 (95.8) 0.80 (0.64-0.99) 0.87 (0.69-1.08) 
2013 3208 (25.8) 135 (4.2) 3073 (95.8) 1.30 (0.99-1.70) 1.40 (1.07-1.83)* 
2014 1547 (12.4) 95 (6.1) 1452 (93.9) 1.23 (1.03-1.62) 1.34 (1.06-1.68)* 
2015 3398 (27.3) 182 (5.4) 3216 (94.6) 0.87 (0.67-1.12) 0.87 (0.68-1.13) 
 
 
Table 4: Estimated epidemiological burden of TB per 100,000; [1, 4, 20-23]. 
 2010 2011 2012 2013 2014 2015  Average 
prevalence 
Global  178 170 169 159 174 142  0.17% 
High burden countries 231 222 216 208 227 195  0.22% 
Ethiopia  394 237 224 211 200 192  0.25% 
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Discussion 
In Ethiopia, the limited diagnostic capacity for TB in 
the community remains a challenge to improving case 
detection rates. In the study region, laboratory 
diagnosis of TB remains mainly in a stage of Ziehl-
Nielseen (ZN) smear microscopyeven in cases with 
suspected infection by drug resistant strains. Authors 
tried to offer the first insight to show the trend of 
smear-positive pulmonary TB in FHRH, Northwest 
Ethiopia, over five years period and have important 
indications for the strategic control of TB in 
community as TB is still a serious public health 
challenge in the study area in particular and Ethiopia in 
general. 
 
In this study, the average prevalence of the overall five 
years smear positive pulmonary TB in FHRH was 
5.2% (649/12442)which is found to be equivalent to 
5200 cases per 100, 000 population. The results of this 
study are consistent with those reported by othersin 
Ethiopia [12-13]. On the other hand, it is lower 
compared to other studies in Ethiopia and elsewhere in 
the world [14-19]. The possible explanation for this 
difference might be due to the fact that this study was 
conducted at the site where TB patients could more 
likely served better medical attention and the sample 
size we employed was quite larger than the previous 
reports. In contrary, according to global TB report of 
the year 2011-2015, the average estimated 
epidemiological burden of TB in Ethiopia was 
250/100000= 0.25% [1, 4, 20-22] which is much lower 
than compared to  our report in the same years (5.2%). 
This partly could be explained by the fact that in the 
present study the subjects were those individuals who 
were clinically suspected for pulmonary TB at the 
tertiary hospital health care level while the WHO 
estimate was based on the community based survey. At 
the same time, our finding is one site report while the 
WHO data was country wide in which disparity is 
likely to happen. 
 
The trend of smear positive pulmonary TB over a five 
years period showed after falling from 6.6% to 4.2% in 
2011 and 2012 , it rose up to 6.1% in 2014 and falling 
from 6.1% to 5.4% in 2014, which might 
indicatesinconsistent intervention measures taken to 
reduce the burden of the disease with time in the 
studied area. However, at the national level the trend of 
TB over the five years period (2011-2015) indicated a 
declined trend (Table 4) [1, 4, 20-23]. Similarly, 
according to WHO report, the global TB incidence has 
fallen by an average of 1.5% per year since 2000 and is 
now 18% lower than the level of 2000 [1]. Moreover, a 
study in China showed a declining trend in the 
incidence of sputum smears positive TB from 2005 to 
2013 [24]. 
 
Unfortunately our finding in general does not show 
declining trend – rather erratic. This could partly be 
explained by inconsistent interventions that the local 
government and other stakeholders might undertake to 
decrease the burden of TB in the studied area. Marking 
2015 as the end of the Millennium Development Goal 
(MDG) era and its replacement with a set of 
Sustainable Development Goals (SDGs) for 2016-
2030, as well the End TB Strategy 2016-2035, our 
finding calls stakeholders to evaluate and strengthen 
their strategies to align their TB prevention and control 
measures with these bold targets. 
 
Risk factors such as age and sex may play an important 
role in the progression of TB infection [25]. However, 
in this study, the disease risk was low for age groups of 
15-29, 30-44 and 45-59 years compared to children (0-
14).There was no significant difference between the 
patient residence, males and females.Furthermore, TB 
infection was high in the year 2013 and 2014. 
 
The main limitations of this study were the lack of 
culture (as no culture facility), chest X- rays and 
clinical findings.Another drawback of our study is the 
lack of the status of TB treatment outcome and HIV, 
which might all have determinant factor to show the 
complete picture of the study subjects in the studied 
area. However, our study report, which generated from 
relatively larger sample size, will be an important 
source that will provides information concerning the 
implementation of TB prevention measures in the study 
area where there is high burden of TB and HIV. 
 
Conclusions:  
In the studied area, there is high prevalence of TB and 
is continuing as a major public health challenge. Thus, 
the intervention strategies to decrease the impact of TB 
have to be evaluated and strengthened. 
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